In addition, DLK2 overexpression was associated with an advanced stage and a poorly differentiated grade, and was correlated with a worse survival outcome in ccRCC patients, indicating that DLK2 may play an oncogenic role and serve as a promising and novel prognostic factor for ccRCC. Here, DLK2 is linked to nonpapillary renal cell carcinoma.